Compare Macy's Inc (M) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macy's Inc vs Smith & Nephew plc — how do they compare? Macy's Inc trades at $24.53 (market cap $6.68B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Macy's Inc pays the higher dividend (3.02%). Which is the better fit depends on your goals.
| M | SNN | |
|---|---|---|
Market Cap | $6.68B | $12.50B |
Sector | Consumer Cyclical | Health |
52-Week High | $26.21 | $38.70 |
52-Week Low | $12.73 | $28.73 |
Enterprise Value | $10.50B | $15.53B |
Dividend Yield | 3.02% | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
